Cochrane Review Group
Musculoskeletal
143 systematic reviews in Musculoskeletal ask 1,956 questions. 28.4% have no studies to answer them, 13% rest on very low certainty evidence and 24.8% reach moderate or high certainty.
Reviews
143
Questions
1,956
current versions
No studies
28.4%
Moderate or high
24.8%
No studies 555 · 28.4%Ungraded 107 · 5.5%Very low 255 · 13%Low 555 · 28.4%Moderate 357 · 18.3%High 127 · 6.5%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Thinnest evidence
All no studies and very low questions| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Methotrexate vs placebo Outcomes(time frame of absolute effects) · children and young people with JIA Methotrexate for juvenile idiopathic arthritis (2024) · Cochrane | no estimate extracted | NR | No studies |
Oral methotrexate plus intra‐articular glucocorticoid vs intra‐articular glucocorticoid alone Treatment responsea · children and young people with JIA Methotrexate for juvenile idiopathic arthritis (2024) · Cochrane | no estimate extracted | NR | No studies |
Oral methotrexate plus intra‐articular glucocorticoid vs intra‐articular glucocorticoid alone Function · children and young people with JIA Methotrexate for juvenile idiopathic arthritis (2024) · Cochrane | no estimate extracted | NR | No studies |
Oral methotrexate plus intra‐articular glucocorticoid vs intra‐articular glucocorticoid alone Pain · children and young people with JIA Methotrexate for juvenile idiopathic arthritis (2024) · Cochrane | no estimate extracted | NR | No studies |
Oral methotrexate plus intra‐articular glucocorticoid vs intra‐articular glucocorticoid alone Participant global assessment of well‐being · children and young people with JIA Methotrexate for juvenile idiopathic arthritis (2024) · Cochrane | no estimate extracted | NR | No studies |
Oral methotrexate plus intra‐articular glucocorticoid vs intra‐articular glucocorticoid alone Serious adverse events(12 months) · children and young people with JIA Methotrexate for juvenile idiopathic arthritis (2024) · Cochrane | no estimate extracted | NR | Very low |
Methotrexate vs alternative disease‐modifying antirheumatic drugs Outcomes(time frame of absolute effects) · children and young people with JIA Methotrexate for juvenile idiopathic arthritis (2024) · Cochrane | no estimate extracted | NR | No studies |
Methotrexate vs alternative disease‐modifying antirheumatic drugs Sustained clinically inactive diseasec · children and young people with JIA Methotrexate for juvenile idiopathic arthritis (2024) · Cochrane | no estimate extracted | NR | No studies |
Methotrexate vs alternative disease‐modifying antirheumatic drugs Pain · children and young people with JIA Methotrexate for juvenile idiopathic arthritis (2024) · Cochrane | no estimate extracted | NR | No studies |
Methotrexate vs placebo Sustained clinically inactive diseasec · children and young people with JIA Methotrexate for juvenile idiopathic arthritis (2024) · Cochrane | no estimate extracted | NR | No studies |
Methotrexate vs placebo Function · children and young people with JIA Methotrexate for juvenile idiopathic arthritis (2024) · Cochrane | no estimate extracted | NR | No studies |
Oral methotrexate plus intra‐articular glucocorticoid vs intra‐articular glucocorticoid alone Outcomes(time frame of absolute effects) · children and young people with JIA Methotrexate for juvenile idiopathic arthritis (2024) · Cochrane | no estimate extracted | NR | No studies |
Reviews 143
Non‐steroidal anti‐inflammatory drugs (NSAIDs) for treating lateral elbow pain in adults
CochraneSoF table
18 questions
Methotrexate for ankylosing spondylitis
CochraneSoF table
7 questions
Etanercept for the treatment of rheumatoid arthritis
CochraneSoF table
25 questions
Retention versus sacrifice of the posterior cruciate ligament in total knee arthroplasty for treating osteoarthritis
CochraneSoF table
21 questions
Acupuncture for treating fibromyalgia
CochraneSoF table
35 questions
Non‐pharmacological interventions for fatigue in rheumatoid arthritis
CochraneSoF table
7 questions
Lifestyle interventions for chronic gout
CochraneSoF table
7 questions
Lifestyle interventions for acute gout
CochraneSoF table
7 questions
Topical herbal therapies for treating osteoarthritis
CochraneSoF table
19 questions
Resistance exercise training for fibromyalgia
CochraneSoF table
19 questions
Cemented, cementless or hybrid fixation options in total knee arthroplasty for osteoarthritis and other non‐traumatic diseases
CochraneSoF table
7 questions
Doxycycline for osteoarthritis of the knee or hip
CochraneSoF table
6 questions
Febuxostat for treating chronic gout
CochraneSoF table
42 questions
Neuromodulators for pain management in rheumatoid arthritis
CochraneSoF table
9 questions
Muscle relaxants for pain management in rheumatoid arthritis
CochraneSoF table
6 questions
Monoamine oxidase inhibitors (MAOIs) for fibromyalgia syndrome
CochraneSoF table
7 questions
Exercise for preventing and treating osteoporosis in postmenopausal women
CochraneSoF table
7 questions
Herbal therapy for treating rheumatoid arthritis
CochraneSoF table
12 questions
Opioid therapy for treating rheumatoid arthritis pain
CochraneSoF table
6 questions
Surgery for lateral elbow pain
CochraneSoF table
13 questions
Safety of non‐steroidal anti‐inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis)
CochraneSoF table
6 questions
Antidepressants for pain management in rheumatoid arthritis
CochraneSoF table
6 questions
Acupuncture for peripheral joint osteoarthritis
CochraneSoF table
12 questions
Therapeutic ultrasound for osteoarthritis of the knee or hip
CochraneSoF table
5 questions
Surgical interventions for the rheumatoid shoulder
CochraneSoF table
7 questions